Lundbeck
HLUN-B.CO
#2744
Rank
โ‚น613.66 B
Marketcap
โ‚น618.52
Share price
-0.80%
Change (1 day)
29.37%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2026 (TTM): โ‚น76.69 Billion

According to Lundbeck's latest financial reports the company's current earnings are โ‚น4.00 Billion. In 2025 the company made an earning of โ‚น73.48 Billion, an increase over its 2024 earnings that were of โ‚น53.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น76.69 B4.37%
2025 โ‚น73.48 B37.43%
2024 โ‚น53.46 B25.74%
2023 โ‚น42.52 B21.77%
2022 โ‚น34.92 B31.57%
2021 โ‚น26.54 B-4.61%
2020 โ‚น27.82 B-45.06%
2019 โ‚น50.65 B-34.04%
2018 โ‚น76.79 B12.83%
2017 โ‚น68.06 B93.99%
2016 โ‚น35.08 B-137.28%
2015 -โ‚น94.11 Billion-1246.24%
2014 โ‚น8.21 B-72.36%
2013 โ‚น29.70 B4.38%
2012 โ‚น28.45 B-55.18%
2011 โ‚น63.49 B5.65%
2010 โ‚น60.09 B-5.9%
2009 โ‚น63.86 B